Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer's Disease Pathology

Research output: Contribution to journalShort surveypeer-review

13 Scopus citations

Abstract

Blood-brain barrier disruption is believed to occur in Alzheimer's disease, which could influence the bioavailability of drugs within the brain. However, in this issue of Neuron, Bien-Ly et al. (2015) report no evidence of widespread blood-brain barrier dysfunction. Blood-brain barrier disruption is believed to occur in Alzheimer's disease, which could influence the bioavailability of drugs within the brain. However, in this issue of Neuron, Bien-Ly et al. (2015) report no evidence of widespread blood-brain barrier dysfunction.

Original languageEnglish
Pages (from-to)237-239
Number of pages3
JournalNeuron
Volume88
Issue number2
DOIs
StatePublished - Oct 21 2015

Fingerprint Dive into the research topics of 'Re-evaluation of the Blood-Brain Barrier in the Presence of Alzheimer's Disease Pathology'. Together they form a unique fingerprint.

Cite this